| RoB 2: a revised tool for assessing risk of bias in randomised trials JAC Sterne, J Savović, MJ Page, RG Elbers, NS Blencowe, I Boutron, ... bmj 366, 2019 | 16880 | 2019 |
| RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 366: l4898 JAC Sterne, J Savović, MJ Page, RG Elbers, NS Blencowe, I Boutron, ... | 519 | 2019 |
| Assessing risk of bias in a non‐randomized study JAC Sterne, MA Hernán, A McAleenan, BC Reeves, JPT Higgins Cochrane handbook for systematic reviews of interventions, 621-641, 2019 | 493 | 2019 |
| The effects of changes to the built environment on the mental health and well-being of adults: Systematic review THM Moore, JM Kesten, JA López-López, S Ijaz, A McAleenan, ... Health & place 53, 237-257, 2018 | 249 | 2018 |
| Smc5–Smc6 mediate DNA double-strand-break repair by promoting sister-chromatid recombination G De Piccoli, F Cortes-Ledesma, G Ira, J Torres-Rosell, S Uhle, S Farmer, ... Nature cell biology 8 (9), 1032-1034, 2006 | 234 | 2006 |
| Screening strategies for atrial fibrillation: a systematic review and cost-effectiveness analysis NJ Welton, A McAleenan, HHZ Thom, P Davies, W Hollingworth, ... Health technology assessment 21 (29), 2017 | 167 | 2017 |
| SUMOylation of the α-kleisin subunit of cohesin is required for DNA damage-induced cohesion A McAleenan, V Cordon-Preciado, A Clemente-Blanco, IC Liu, N Sen, ... Current Biology 22 (17), 1564-1575, 2012 | 98 | 2012 |
| Increased Secretion of Lipoproteins in Transgenic Mice Expressing Human D374Y PCSK9 Under Physiological Genetic Control B Herbert, D Patel, SN Waddington, ER Eden, A McAleenan, XM Sun, ... Arteriosclerosis, thrombosis, and vascular biology 30 (7), 1333-1339, 2010 | 88 | 2010 |
| Post-replicative repair involves separase-dependent removal of the kleisin subunit of cohesin A McAleenan, A Clemente-Blanco, V Cordon-Preciado, N Sen, M Esteras, ... Nature 493 (7431), 250-254, 2013 | 69 | 2013 |
| Treatment interventions to maintain abstinence from alcohol in primary care: systematic review and network meta-analysis HY Cheng, LA McGuinness, RG Elbers, GJ MacArthur, A Taylor, ... bmj 371, 2020 | 65 | 2020 |
| RoB 2: A revised Cochrane risk-of-bias tool for randomized trials JAC Sterne, J Savović, MJ Page, RG Elbers, NS Blencowe, I Boutron, ... Bmj 366, l4898, 2019 | 63 | 2019 |
| MGMT promoter methylation testing to predict overall survival in people with glioblastoma treated with temozolomide: a comprehensive meta-analysis based on a … S Brandner, A McAleenan, C Kelly, F Spiga, HY Cheng, S Dawson, ... Neuro-oncology 23 (9), 1457-1469, 2021 | 51 | 2021 |
| Prevalence of BRAFV600 in glioma and use of BRAF Inhibitors in patients with BRAFV600 mutation-positive glioma: systematic review LJ Andrews, ZA Thornton, SS Saincher, IY Yao, S Dawson, ... Neuro-oncology 24 (4), 528-540, 2022 | 40 | 2022 |
| A tool to assess risk of bias in non-randomized follow-up studies of exposure effects (ROBINS-E) JPT Higgins, RL Morgan, AA Rooney, KW Taylor, KA Thayer, RA Silva, ... Environment international 186, 108602, 2024 | 34 | 2024 |
| Optimizing the design and analysis of clinical trials for antibacterials against multidrug-resistant organisms: a white paper from COMBACTE’s STAT-Net MEA de Kraker, H Sommer, F de Velde, I Gravestock, E Weiss, ... Clinical Infectious Diseases 67 (12), 1922-1931, 2018 | 34 | 2018 |
| Use of Mendelian Randomization for Identifying Risk Factors for Brain Tumors AE Howell, J Zheng, PC Haycock, A McAleenan, C Relton, RM Martin, ... Frontiers in genetics 9, 525, 2018 | 31 | 2018 |
| Prognostic value of test (s) for O6‐methylguanine–DNA methyltransferase (MGMT) promoter methylation for predicting overall survival in people with glioblastoma treated with … A McAleenan, C Kelly, F Spiga, A Kernohan, HY Cheng, S Dawson, ... Cochrane Database of Systematic Reviews, 2021 | 29 | 2021 |
| Transthoracic clamp versus endoaortic balloon occlusion in minimally invasive mitral valve surgery: a systematic review and meta-analysis PM Rival, THM Moore, A McAleenan, H Hamilton, Z Du Toit, E Akowuah, ... European Journal of Cardio-Thoracic Surgery 56 (4), 643-653, 2019 | 29 | 2019 |
| Methodological features of clinical pharmacokinetic–pharmacodynamic studies of antibacterials and antifungals: a systematic review A McAleenan, PG Ambrose, SM Bhavnani, GL Drusano, WW Hope, ... Journal of Antimicrobial Chemotherapy 75 (6), 1374-1389, 2020 | 26 | 2020 |
| Testing for causality between systematically identified risk factors and glioma: a Mendelian randomization study AE Howell, JW Robinson, RE Wootton, A McAleenan, S Tsavachidis, ... Bmc Cancer 20, 1-11, 2020 | 23 | 2020 |
